DE:RTQ1 Stock Latest News
Company AnnouncementsAvacta to Showcase AVA6000 and AVA6103 Data at ESMO 20262w ago
Company AnnouncementsAvacta to Present Interim Results as It Advances Next-Generation Oncology Pipeline3w ago
Company AnnouncementsAvacta Raises £12.5m to Extend Runway and Advance Oncology Pipeline3w ago
Company AnnouncementsAvacta launches £12.5m share placing to fund oncology pipeline and extend cash runway3w ago
Company AnnouncementsAvacta Enters AIM Capital Access Window for Equity Raise After AVA6103 Milestone1M ago
Company AnnouncementsAvacta strengthens finances as pre|CISION cancer pipeline gains clinical momentum1M agoCompany AnnouncementsAvacta’s pre|CISION Platform Wins UK Pharma R&D Award as AVA6103 Advances in Oncology Trials1M ago
Company AnnouncementsAvacta’s AVA6103 Trial Data Boost Confidence in Next-Gen Pancreatic Cancer Therapy1M ago
Company AnnouncementsAvacta’s AVA6103 Hits Clinical Proof of Mechanism, Outperforms Enhertu in Preclinical Study1M ago- Company AnnouncementsAvacta strengthens board with new audit chair amid oncology push1M ago
Company AnnouncementsAvacta Cuts Convertible Bond Balance with Accelerated Cash Repayment1M ago
Company AnnouncementsAvacta awards management share options tied to oncology pipeline milestones2M ago
Company AnnouncementsAvacta Cuts Convertible Bond Principal with Accelerated Cash Repayment3M agoCompany AnnouncementsAvacta Strengthens Board With Appointment of Patrick Vink as Deputy Chairman3M ago
- Company AnnouncementsAvacta Wins FDA Backing for Single Pivotal Trial of AVA6000 in Salivary Gland Cancer4M ago
Company AnnouncementsAvacta Wins Strong Shareholder Backing as All AGM Resolutions Pass4M ago
Company AnnouncementsAvacta Extends Cash Runway as pre|CISION Oncology Pipeline Advances4M ago
Company AnnouncementsAvacta Raises £9m to Cut Convertible Debt and Fund Oncology Pipeline5M ago
Company AnnouncementsAvacta applies for AIM block listing to cover employee share options5M agoCompany AnnouncementsAvacta Reports Strong Early Efficacy and Cardiac Safety for AVA6000 in Salivary Gland Cancer5M ago